In a simple definition, cancer is a disease of the cells, which is caused by gene mutations. For a proportion of patients, including women with hormone receptor positive breast cancer, gene expression profiling has a substantial impact on treatment decision-making by determining which patients might—or might not—respond to particular treatment options.
“Patients are counting on us, and this remains the best time to be involved in cancer research,” W. Kimryn Rathmell said to The Cancer Letter.
